Posted on November 5, 202011/5/20
Do Germany’s New Hemophilia Regulations Have Wider-Reaching Implications?
Posted on October 14, 202010/14/20
Italy Tackles HTA, Pricing and Reimbursement Reforms
Posted on September 25, 20209/25/20
Trends in HTA Decisions
Posted on September 21, 20209/21/20
Navigate the Complexity of Proposed CMS Medicaid Rule
Posted on September 14, 20209/14/20
At the COVID-19 Finish Line, How Do We Price The Winning Vaccine?
Posted on September 11, 20209/11/20
How to Get Your Digital Therapeutic Approved & Reimbursed in Europe and the U.S.
Posted on September 2, 20209/2/20
CMS Announces Medicare Coverage for FDA-Designated Breakthrough Devices. What Does This Mean?
Posted on July 16, 20207/16/20
CMS Proposed Medicaid Rule: Best Price Impacts of Value-Based Purchasing, Co-Pay Assistance Programs, and More
Posted on July 15, 20207/15/20
Is BeNeLuxA Equipped for a Zolgensma Assessment?
Posted on July 7, 20207/7/20